UNLABELLED: Although osteopontin (OPN) is induced in alcoholic patients, its role in the pathophysiology of alcoholic liver disease (ALD) remains unclear. Increased translocation of lipopolysaccharide (LPS) from the gut is key for the onset of ALD because it promotes macrophage infiltration and activation, tumor necrosis factor-α (TNFα) production, and liver injury. Since OPN is protective for the intestinal mucosa, we postulated that enhancing OPN expression in the liver and consequently in the blood and/or in the gut could protect from early alcohol-induced liver injury. Wild-type (WT), OPN knockout (Opn(-/-)), and transgenic mice overexpressing OPN in hepatocytes (Opn(HEP) Tg) were fed either the control or the ethanol Lieber-DeCarli diet. Ethanol increased hepatic, plasma, biliary, and fecal OPN more in Opn(HEP) Tg than in WT mice. Steatosis was less in ethanol-treated Opn(HEP) Tg mice as shown by decreased liver-to-body weight ratio, hepatic triglycerides, the steatosis score, oil red-O staining, and lipid peroxidation. There was also less inflammation and liver injury as demonstrated by lower alanine aminotransferase (ALT) activity, hepatocyte ballooning degeneration, LPS levels, the inflammation score, and the number of macrophages and TNFα(+) cells. To establish if OPN could limit LPS availability and its noxious effects in the liver, binding studies were performed. OPN showed binding affinity for LPS which prevented macrophage activation, reactive oxygen, and nitrogen species generation and TNFα production. Treatment with milk OPN (m-OPN) blocked LPS translocation in vivo and protected from early alcohol-induced liver injury. CONCLUSION: Natural induction plus forced overexpression of OPN in the liver or treatment with m-OPN protect from early alcohol-induced liver injury by blocking the gut-derived LPS and TNFα effects in the liver.
UNLABELLED: Although osteopontin (OPN) is induced in alcoholicpatients, its role in the pathophysiology of alcoholic liver disease (ALD) remains unclear. Increased translocation of lipopolysaccharide (LPS) from the gut is key for the onset of ALD because it promotes macrophage infiltration and activation, tumornecrosis factor-α (TNFα) production, and liver injury. Since OPN is protective for the intestinal mucosa, we postulated that enhancing OPN expression in the liver and consequently in the blood and/or in the gut could protect from early alcohol-induced liver injury. Wild-type (WT), OPN knockout (Opn(-/-)), and transgenic mice overexpressing OPN in hepatocytes (Opn(HEP) Tg) were fed either the control or the ethanol Lieber-DeCarli diet. Ethanol increased hepatic, plasma, biliary, and fecal OPN more in Opn(HEP) Tg than in WT mice. Steatosis was less in ethanol-treated Opn(HEP) Tgmice as shown by decreased liver-to-body weight ratio, hepatic triglycerides, the steatosis score, oil red-O staining, and lipid peroxidation. There was also less inflammation and liver injury as demonstrated by lower alanine aminotransferase (ALT) activity, hepatocyte ballooning degeneration, LPS levels, the inflammation score, and the number of macrophages and TNFα(+) cells. To establish if OPN could limit LPS availability and its noxious effects in the liver, binding studies were performed. OPN showed binding affinity for LPS which prevented macrophage activation, reactive oxygen, and nitrogen species generation and TNFα production. Treatment with milk OPN (m-OPN) blocked LPS translocation in vivo and protected from early alcohol-induced liver injury. CONCLUSION: Natural induction plus forced overexpression of OPN in the liver or treatment with m-OPN protect from early alcohol-induced liver injury by blocking the gut-derived LPS and TNFα effects in the liver.
Authors: S Ashkar; G F Weber; V Panoutsakopoulou; M E Sanchirico; M Jansson; S Zawaideh; S R Rittling; D T Denhardt; M J Glimcher; H Cantor Journal: Science Date: 2000-02-04 Impact factor: 47.728
Authors: Honghui Yu; Tuanzhu Ha; Li Liu; Xiaohui Wang; Ming Gao; Jim Kelley; Race Kao; David Williams; Chuanfu Li Journal: Biochim Biophys Acta Date: 2012-05-14
Authors: N Enomoto; K Ikejima; S Yamashina; M Hirose; H Shimizu; T Kitamura; Y Takei; N Sato And; R G Thurman Journal: Alcohol Clin Exp Res Date: 2001-06 Impact factor: 3.455
Authors: Oriol Morales-Ibanez; Marlene Domínguez; Sung H Ki; Miguel Marcos; Javier F Chaves; Eric Nguyen-Khac; Hakim Houchi; Silvia Affò; Pau Sancho-Bru; José Altamirano; Javier Michelena; Juan Carlos García-Pagán; Juan G Abraldes; Vicente Arroyo; Juan Caballería; Francisco-Javier Laso; Bin Gao; Ramón Bataller Journal: Hepatology Date: 2013-08-19 Impact factor: 17.425
Authors: Atul Sahai; Padmini Malladi; Hector Melin-Aldana; Richard M Green; Peter F Whitington Journal: Am J Physiol Gastrointest Liver Physiol Date: 2004-03-25 Impact factor: 4.052
Authors: Duminda B Suraweera; Ashley N Weeratunga; Robert W Hu; Stephen J Pandol; Richard Hu Journal: World J Gastrointest Pathophysiol Date: 2015-11-15
Authors: Rebecca L McCullough; Megan R McMullen; Dola Das; Sanjoy Roychowdhury; Michael G Strainic; M Edward Medof; Laura E Nagy Journal: Mol Immunol Date: 2016-06-06 Impact factor: 4.407